{
  "id": 7815502,
  "title": "Skyhawk racks up more support for Huntington’s drug",
  "url": "https://urgent.news/2026/09/16/skyhawk-racks-up-more-support-for-huntingtons-drug",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-16T13:05:57.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/skyhawk-huntingtons-drug-rna-splicing-results/830537/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The Fidelity-backed biotech now has 15-month data from a small study of its RNA-splicing therapy.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "Skyhawk says its Huntington’s drug improved symptoms in extension to Phase 1/2 trial",
        "url": "https://urgent.news/2026/09/16/skyhawk-says-its-huntingtons-drug-improved-symptoms-in-extension-to",
        "published": "2026-09-16T10:56:58.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}